CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, M.D., Ph.D., as the newly established SVP, Chief Translation Medicine Officer
-Dr. Tse’s Extensive Track Record in Oncology Early Clinical Development Will Strengthen CStone’s Core Competence as a Clinical Development Engine and Solidify CStone’s Position Among Leading Innovative Biopharma Companies in…